INTERPACE BIOSCIENCES, INC. (IDXG)
Surgical & Medical Instruments & Apparatus · Healthcare · $44M
Intrinsic Value (Consensus)
$0.00
Current Price
$1.57
Margin of Safety
0%
At Fair Value
Value: $0
Price: $2
Valuation Model Estimates
Current Price: $1.57
DCF (Discounted Cash Flow)
$12.85
Graham Number
$9.12
Earnings Power Value
$8.86
Relative Value (P/E)
$14.64
Dividend Discount Model
Not applicable
—
Consensus Value
$0.00
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.2%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
67
Profitability
25/25
Strength
23/25
Valuation
12/25
Growth
7/25
Financial Health Signals
Declining revenue — top line is shrinking
Strong profitability — ROE of 110% (above 20% is excellent)
High free cash flow yield (12.5%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $0.73
- EPS (Forward)
- $0.77
- Book Value
- $5.05
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 109.9%
- Debt/Equity
- 35%
- Revenue Growth
- -17.5%
- Earnings Growth
- 5.2%
- Dividend Yield
- N/A
- Beta
- 0.66
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance